Complement takes its Toll: An inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a

Anaesthesia

Volumn 67, Issue 1, 2012, Pages 60-64

  Holst, B ^a   Raby, A C ^a   Hall, J E ^a   Labeta M O ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPLEMENT SYSTEM; CYTOKINE RELEASE; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SEPSIS; SIGNAL TRANSDUCTION; TH1 CELL; VENTILATOR ASSOCIATED PNEUMONIA;

ANIMALS; BACTERIA; HUMANS; INFLAMMATION; RECEPTOR CROSS-TALK; RECEPTOR, ANAPHYLATOXIN C5A; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 83455196095     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.07011.x     Document Type: Article

References (30)

1. Kumar H, Kawai T, Akira S,. Toll-like receptors and innate immunity. Biochemical and Biophysical Research Communications 2009; 388: 621-5.
2. Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M,. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Molecular Medicine 2011; 17: 317-20.
3. Montz H, Koch KC, Zierz R, Gotze O,. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 1991; 74: 373-9.
4. Kanzler H, Barrat FJ, Hessel EM, Coffman RL,. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Medicine 2007; 13: 552-9. (Pubitemid 46830615)
5. Mollnes TE, Christiansen D, Brekke OL, Espevik T,. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Advances in Experimental Medicine and Biology 2008; 632: 253-63.
6. Akira S, Takeda K,. Toll-like receptor signalling. Nature Reviews: Immunology 2004; 4: 499-511. (Pubitemid 38931765)
7. Bamberg CE, Mackay CR, Lee H, et al., The C5a receptor C5L2 is a negative modulator of C5aR-mediated signal transduction. Journal of Biological Chemistry 2010; 285: 7633-44.
8. Chen NJ, Mirtsos C, Suh D, et al., C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007; 446: 203-7. (Pubitemid 46398661)
9. Rittirsch D, Flierl MA, Nadeau BA, et al., Functional roles for C5a receptors in sepsis. Nature Medicine 2008; 14: 551-7. (Pubitemid 351655216)
10. Okusawa S, Dinarello CA, Yancey KB, et al., C5a induction of human interleukin 1: Synergistic effect with Endotoxin or Interferon Î. Journal of Immunology 1987; 139: 2635-40. (Pubitemid 17153938)
11. Mack C, Jungermann K, Gotze O, Schieferdecker HL,. Anaphylatoxin C5a actions in rat liver: synergistic enhancement by C5a of lipopolysaccharide- dependent α2-macroglobulin gene expression in hepatocytes via IL-6 release from Kuppfer cells. Journal of Immunology 2001; 167: 3972-9. (Pubitemid 32910843)
12. Laudes IJ, Chu JC, Huber-lang M, et al., Expression and function of C5a receptor in mouse microvascular endothelial cells. Journal of Immunology 2002; 169: 5962-70. (Pubitemid 35299387)
13. Riedemann NC, Guo RF, Hollmann TJ, et al., Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB Journal 2004; 18: 370-2.
14. Kuhns DB, Long Priel DA, Gallin JI,. Induction of human monocytes interleukin (IL) -8 by fibrinogen through the Toll-like receptor pathway. Inflammation 2007; 30: 178-88. (Pubitemid 47573147)
15. Wang L, Han G, Wang R, et al., Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis. Clinical Immunology 2010; 137: 157-65.
16. Zhang X, Kimura Y, Fang C, et al., Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007; 110: 228-36. (Pubitemid 47026839)
17. Meduri GU, Headley S, Kohler G, et al., Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107: 1062-73.
18. Casey LC, Balk RA, Bone RC,. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Annals of Internal Medicine 1993; 119: 771-8. (Pubitemid 24012641)
19. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E,. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75. (Pubitemid 23070764)
20. Wittmann M, Zwirner J, Larsson VA, et al., C5a suppresses the production of IL-12 by IFN-Î-primed and lipopolysaccharide-challenged human monocytes. Journal of Immunology 1999; 162: 6763-9. (Pubitemid 29309403)
21. Braun MC, Lahey E, Kelsall BL,. Selective suppression of IL-12 production by chemoattractants. Journal of Immunology 2000; 164: 3009-17. (Pubitemid 30148960)
22. Hawlisch H, Belkaid Y, Baelder R, Hildeman D, Gerard C, Kohl J,. C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 2005; 22: 415-26. (Pubitemid 40545108)
23. La Sala A, Gadina M, Kelsall B,. Gi-protein-dependent inhibition of IL-12 production is mediated by activation of the phophatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. Journal of Immunology 2005; 175: 2994-9. (Pubitemid 41170517)
24. Liang S, Krauss JL, Domon H, et al., The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. Journal of Immunology 2011; 186: 869-77.
25. Spolarics Z, Siddigi M, Siegel JH, et al., Depressed interleukin-12- producing activity by monocytes correlates with adverse clinical course and a shift towards Th2-type lymphocyte pattern in severely injured male trauma patients. Critical Care Medicine 2003; 31: 1722-9. (Pubitemid 36714228)
26. Wang M, Krauss JL, Domon H, et al., Microbial hijacking of Complement-Toll-like receptor crosstalk. Science Signaling 2011; 3: 1-16.
27. Cairns S, Thomas JG, Hooper SJ, et al., Molceular analysis of microbial communities in endotracheal tube biofilms. PLoS ONE 2011; 6: e14759.
28. Raby AC, Holst B, Davies J, et al., Toll-like receptor activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. European Journal of Immunology 2011; 41: 2741-52.
29. Opal SM, Scannon PJ, Vincent J-L, et al., Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. Journal of Infectious Diseases 1999; 180: 1584-9. (Pubitemid 29506461)
30. Remick DG,. Pathophysiology of sepsis. American Journal of Pathology 2007; 170: 1435-44. (Pubitemid 47339289)